NRx Pharmaceuticals Receives FDA Approval for Preservative-Free Ketamine
NRx Pharmaceuticals said the FDA approved its preservative-free ketamine application ahead of the agency’s November 10 goal date.
NRx Pharmaceuticals received FDA approval for its Preservative-Free Ketamine application ahead of the agency’s November 10 goal date.Key Highlights:Original SEC Filing: NRX Pharmaceuticals, Inc. [ NRXP ] - 8-K - Nov. 02, 2026This is an AI-powered summary. It may contain inaccuracies.
Consider verif…